(19)
(11) EP 4 436 553 A1

(12)

(43) Date of publication:
02.10.2024 Bulletin 2024/40

(21) Application number: 22822654.4

(22) Date of filing: 21.11.2022
(51) International Patent Classification (IPC): 
A61K 9/20(2006.01)
A61P 7/02(2006.01)
A61K 31/444(2006.01)
A61K 9/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/0056; A61K 9/2054; A61K 9/2095; A61K 31/444; A61P 7/02
(86) International application number:
PCT/IB2022/061193
(87) International publication number:
WO 2023/089575 (25.05.2023 Gazette 2023/21)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 22.11.2021 IN 202121053646
19.01.2022 EP 22152174

(71) Applicant: Intas Pharmaceuticals Ltd.
Ahmedabad - 380054, Gujarat (IN)

(72) Inventors:
  • PÉREZ PÉREZ, Jesús Manuel
    41703 Sevilla (ES)
  • MÁRQUEZ QUIDIELLO, María Teresa
    41703 Sevilla Sevilla (ES)
  • MUÑOZ RUIZ, Angel José
    41703 Sevilla Sevilla (ES)
  • LLUCH LORES, María Carmen
    08039 Barcelona (ES)
  • FORMOSA MÁRQUEZ, Xavier
    08039 Barcelona (ES)

(74) Representative: Ter Meer Steinmeister & Partner 
Patentanwälte mbB Nymphenburger Straße 4
80335 München
80335 München (DE)

   


(54) AN ORODISPERSIBLE PHARMACEUTICAL DOSAGE FORM OF EDOXABAN